Identification of the gene that codes for the σ2 receptor

Author:

Alon Assaf,Schmidt Hayden R.,Wood Michael D.,Sahn James J.,Martin Stephen F.,Kruse Andrew C.ORCID

Abstract

The σ2 receptor is an enigmatic protein that has attracted significant attention because of its involvement in diseases as diverse as cancer and neurological disorders. Unlike virtually all other receptors of medical interest, it has eluded molecular cloning since its discovery, and the gene that codes for the receptor remains unknown, precluding the use of modern biological methods to study its function. Using a chemical biology approach, we purified the σ2 receptor from tissue, revealing its identity as TMEM97, an endoplasmic reticulum-resident transmembrane protein that regulates the sterol transporter NPC1. We show that TMEM97 possesses the full suite of molecular properties that define the σ2 receptor, and we identify Asp29 and Asp56 as essential for ligand recognition. Cloning the σ2 receptor resolves a longstanding mystery and will enable therapeutic targeting of this potential drug target.

Funder

HHS | National Institutes of Health

Vallee Foundation

Harvard Brain Science Initiative

Esther A. and Joseph Klingenstein Fund

Welch Foundation

National Science Foundation

BrightFocus Foundation

Texas Health Catalyst Program

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference49 articles.

1. A Brief History of G-Protein Coupled Receptors (Nobel Lecture)

2. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog;Martin;J Pharmacol Exp Ther,1976

3. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain

4. Abramson Cancer Center of the University of Pennsylvania (2014) Imaging of in vivo sigma-2 receptor expression with 18F ISO-1 positron emission tomography (PET/CT) in primary breast cancer. Clinical trial NCT02762110. Available at https://clinicaltrials.gov/ct2/show/NCT02762110?term=NCT02762110&rank=1. Accessed November 2, 2016.

5. Cognition Therapeutics (2016) Clinical trial of CT1812 in mild to moderate Alzheimer's Disease. Clinical trial NCT02907567. Available at https://clinicaltrials.gov/ct2/show/NCT02907567?term=NCT02907567&rank=1. Accessed November 2, 2016.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3